Buffington Mohr McNeal’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $285K | Sell |
11,262
-1,200
| -10% | -$31.4K | 0.06% | 92 |
|
|
2024
Q4 | $331K | Buy |
+12,462
| New | +$338K | 0.05% | 108 |
|
|
2024
Q1 | – | Sell |
-17,650
| Closed | -$508K | – | 133 |
|
|
2023
Q4 | $508K | Buy |
17,650
+5,200
| +42% | +$157K | 0.1% | 91 |
|
|
2023
Q3 | $413K | Buy |
12,450
+1,114
| +10% | +$39.4K | 0.09% | 97 |
|
|
2023
Q2 | $416K | Sell |
11,336
-3,350
| -23% | -$130K | 0.09% | 94 |
|
|
2023
Q1 | $599K | Sell |
14,686
-693
| -5% | -$29.9K | 0.14% | 89 |
|
|
2022
Q4 | $788K | Sell |
15,379
-1,499
| -9% | -$71.9K | 0.18% | 77 |
|
|
2022
Q3 | $739K | Buy |
16,878
+93
| +0.6% | +$4.52K | 0.18% | 80 |
|
|
2022
Q2 | $880K | Buy |
16,785
+1,547
| +10% | +$78.8K | 0.19% | 77 |
|
|
2022
Q1 | $789K | Buy |
15,238
+1
| +0% | +$52 | 0.15% | 85 |
|
|
2021
Q4 | $900K | Buy |
15,237
+3,087
| +25% | +$153K | 0.15% | 85 |
|
|
2021
Q3 | $523K | Buy |
12,150
+1
| +0% | +$44 | 0.1% | 92 |
|
|
2021
Q2 | $476K | Hold |
12,149
| – | – | 0.09% | 100 |
|
|
2021
Q1 | $440K | Buy |
12,149
+2,819
| +30% | +$100K | 0.09% | 99 |
|
|
2020
Q4 | $343K | Sell |
9,330
-410
| -4% | -$15K | 0.08% | 102 |
|
|
2020
Q3 | $339K | Sell |
9,740
-1,054
| -10% | -$37K | 0.09% | 100 |
|
|
2020
Q2 | $335K | Buy |
10,794
+167
| +2% | +$5.67K | 0.09% | 98 |
|
|
2020
Q1 | $329K | Hold |
10,627
| – | – | 0.11% | 94 |
|
|
2019
Q4 | $395K | Sell |
10,627
-258
| -2% | -$9.19K | 0.11% | 97 |
|
|
2019
Q3 | $371K | Buy |
10,885
+439
| +4% | +$16K | 0.11% | 99 |
|
|
2019
Q2 | $429K | Sell |
10,446
-35
| -0.3% | -$1.39K | 0.13% | 96 |
|
|
2019
Q1 | $422K | Buy |
10,481
+368
| +4% | +$14.7K | 0.14% | 97 |
|
|
2018
Q4 | $419K | Hold |
10,113
| – | – | 0.17% | 95 |
|
|
2018
Q3 | $423K | Buy |
10,113
+29
| +0.3% | +$1.12K | 0.15% | 98 |
|
|
2018
Q2 | $347K | Buy |
10,084
+45
| +0.4% | +$1.54K | 0.13% | 106 |
|
|
2018
Q1 | $338K | Hold |
10,039
| – | – | 0.13% | 103 |
|
|
2017
Q4 | $345K | Hold |
10,039
| – | – | 0.13% | 102 |
|
|
2017
Q3 | $339K | Sell |
10,039
-2,319
| -19% | -$74.5K | 0.13% | 106 |
|
|
2017
Q2 | $394K | Sell |
12,358
-1,866
| -13% | -$58.8K | 0.16% | 104 |
|
|
2017
Q1 | $462K | Buy |
14,224
+2,320
| +19% | +$73.1K | 0.2% | 83 |
|
|
2016
Q4 | $367K | Sell |
11,904
-74
| -0.6% | -$2.26K | 0.14% | 91 |
|
|
2016
Q3 | $384K | Sell |
11,978
-271
| -2% | -$9.06K | 0.16% | 90 |
|
|
2016
Q2 | $409K | Hold |
12,249
| – | – | 0.18% | 89 |
|
|
2016
Q1 | $344K | Buy |
12,249
+345
| +3% | +$9.86K | 0.15% | 104 |
|
|
2015
Q4 | $365K | Buy |
+11,904
| New | +$374K | 0.2% | 72 |
|
Other funds holding PFE
TIM
Buffington Mohr McNeal's PFE Position: Q1 2025 in Review
Buffington Mohr McNeal reduced its Pfizer (PFE) stake by 9.6% in Q1 2025, selling an estimated $31.4K and leaving 11,262 shares worth $285K. The position accounts for 0.06% of the portfolio, ranked #92.
Buffington Mohr McNeal first reported a position in PFE in Q4 2015 and has held it in 35 quarters since. The position peaked at $900K in Q4 2021. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.
- Buffington Mohr McNeal held 11,262 shares of Pfizer worth $285K as of Q1 2025.
- Buffington Mohr McNeal sold 1,200 Pfizer shares in Q1 2025, an estimated $31.4K.
- Pfizer made up 0.06% of Buffington Mohr McNeal's portfolio in Q1 2025, its #92 holding.
- Buffington Mohr McNeal first reported a position in Pfizer in Q4 2015 and has held it in 35 quarters since.
- Buffington Mohr McNeal's Pfizer position peaked at $900K in Q4 2021.
- 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.
Based on Buffington Mohr McNeal's 13F filing for Q1 2025, filed 28 Apr 2025.